Literature DB >> 34956468

1H NMR metabolomic profiling of human cerebrospinal fluid in aging process.

Huan-Tang Lin1,2,3, Mei-Ling Cheng4,5,6, Chi-Jen Lo4, Wen-Chuin Hsu2,7, Gigin Lin8,9, Fu-Chao Liu1,2.   

Abstract

The molecular process of biological aging might be accompanied by significant metabolic derangement, especially in the central nervous system (CNS), since the brain has an enormous energy demand. However, the metabolic signature of the aging process in cerebrospinal fluid (CSF) has not been thoroughly investigated, especially in the Asian population. In this prospective cohort study on CSF metabolomics using proton nuclear magnetic resonance (NMR) spectroscopy, fasting CSF samples from 75 cognitively unimpaired patients aged 20-92 years without diabetes or obesity, undergoing spinal anesthesia for elective surgery were analyzed. Several metabolites in CSF samples were identified as having a significant association with the aging process in cerebral circulation; among the metabolites, the levels of alanine, citrate, creatinine, lactate, leucine, tyrosine, and valine significantly increased in old patients compared to those in young patients. The combined CSF metabolite alterations in citrate, lactate, leucine, tyrosine, and valine had a superior correlation with the aging process in all age groups. In conclusion, our pilot study of aging CSF metabolomics in the Taiwanese population presents significantly altered CSF metabolites with potential relevance to the aging process. These metabolic alterations in CSF samples might imply increasing anaerobic glycolysis, mitochondrial dysfunction, and decreasing glucose utilization in cerebral circulation in aged patients. AJTR
Copyright © 2021.

Entities:  

Keywords:  Aging process; cerebrospinal fluid; metabolomics; nuclear magnetic resonance

Year:  2021        PMID: 34956468      PMCID: PMC8661231     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  38 in total

Review 1.  Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation.

Authors:  Mireille Bélanger; Igor Allaman; Pierre J Magistretti
Journal:  Cell Metab       Date:  2011-12-07       Impact factor: 27.287

2.  Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's disease.

Authors:  Miles Trupp; Pär Jonsson; Annika Ohrfelt; Henrik Zetterberg; Ogonna Obudulu; Linus Malm; Anna Wuolikainen; Jan Linder; Thomas Moritz; Kaj Blennow; Henrik Antti; Lars Forsgren
Journal:  J Parkinsons Dis       Date:  2014       Impact factor: 5.568

Review 3.  Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans.

Authors:  Stephanie Kullmann; Martin Heni; Manfred Hallschmid; Andreas Fritsche; Hubert Preissl; Hans-Ulrich Häring
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

4.  Leucine-rich α2-glycoprotein overexpression in the brain contributes to memory impairment.

Authors:  Chihiro Akiba; Madoka Nakajima; Masakazu Miyajima; Ikuko Ogino; Masami Miura; Ritsuko Inoue; Eri Nakamura; Fumio Kanai; Norihiro Tada; Miyuki Kunichika; Mitsutaka Yoshida; Kinya Nishimura; Akihide Kondo; Hidenori Sugano; Hajime Arai
Journal:  Neurobiol Aging       Date:  2017-08-24       Impact factor: 4.673

5.  NMR metabonomics of cerebrospinal fluid distinguishes between Parkinson's disease and controls.

Authors:  Anders Öhman; Lars Forsgren
Journal:  Neurosci Lett       Date:  2015-03-27       Impact factor: 3.046

6.  Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients.

Authors:  Alex M Dickens; Daniel C Anthony; Reena Deutsch; Michelle M Mielke; Timothy D W Claridge; Igor Grant; Donald Franklin; Debra Rosario; Thomas Marcotte; Scott Letendre; Justin C McArthur; Norman J Haughey
Journal:  AIDS       Date:  2015-03-13       Impact factor: 4.177

7.  Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.

Authors:  Claudio Liguori; Agostino Chiaravalloti; Giuseppe Sancesario; Alessandro Stefani; Giulia Maria Sancesario; Nicola Biagio Mercuri; Orazio Schillaci; Mariangela Pierantozzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-05-25       Impact factor: 9.236

8.  Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults.

Authors:  Gene L Bowman; Loïc Dayon; Richard Kirkland; Jérôme Wojcik; Gwendoline Peyratout; India C Severin; Hugues Henry; Aikaterini Oikonomidi; Eugenia Migliavacca; Michael Bacher; Julius Popp
Journal:  Alzheimers Dement       Date:  2018-08-14       Impact factor: 21.566

9.  Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping.

Authors:  Anthony C Dona; Beatriz Jiménez; Hartmut Schäfer; Eberhard Humpfer; Manfred Spraul; Matthew R Lewis; Jake T M Pearce; Elaine Holmes; John C Lindon; Jeremy K Nicholson
Journal:  Anal Chem       Date:  2014-09-16       Impact factor: 6.986

10.  MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights.

Authors:  Zhiqiang Pang; Jasmine Chong; Guangyan Zhou; David Anderson de Lima Morais; Le Chang; Michel Barrette; Carol Gauthier; Pierre-Étienne Jacques; Shuzhao Li; Jianguo Xia
Journal:  Nucleic Acids Res       Date:  2021-05-21       Impact factor: 16.971

View more
  1 in total

Review 1.  Metabolites and Biomarker Compounds of Neurodegenerative Diseases in Cerebrospinal Fluid.

Authors:  Keiji Wakamatsu; Yoichi Chiba; Ryuta Murakami; Yumi Miyai; Koichi Matsumoto; Masaki Kamada; Wakako Nonaka; Naoya Uemura; Ken Yanase; Masaki Ueno
Journal:  Metabolites       Date:  2022-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.